英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:


请选择你想看的字典辞典:
单词字典翻译
Tirosh查看 Tirosh 在百度字典中的解释百度英翻中〔查看〕
Tirosh查看 Tirosh 在Google字典中的解释Google英翻中〔查看〕
Tirosh查看 Tirosh 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Guardant Health | Conquering Cancer With Data
    Guardant Health is a leading precision medicine company focused on transforming patient care and conquering cancer with data
  • Our Locations | Guardant Health
    Cancer knows no boundaries, which is why Guardant Health has teams collaborating globally to help conquer cancer Explore our locations
  • Careers | Guardant Health
    Join a team of diverse and passionate individuals, motivated to transform cancer care for patients at all stages of the disease
  • Our Story | Guardant Health
    Our mission is to conquer cancer with data It's an ambitious pursuit that requires a singular focus and a relentless commitment to patients
  • Shield™ for Cancer Screening - Guardant Health
    Explore our FDA-approved Shield™ blood-based screening test Discover how our advanced technology detects cancer early, when it's most treatable
  • Contact Us | Guardant Health
    Our support teams are committed to providing the best support possible Contact us if you have questions, need assistance, or like to access our Whistleblower Hotline
  • Guardant Complete® for Early and Advanced Stage Cancer
    Guardant Complete, a comprehensive portfolio of liquid and tissue precision oncology tests combined with best-in-class customer service
  • For Healthcare Providers | Guardant Health
    Explore Guardant Health's integrated solutions for cancer care From diagnosis to treatment and management, we provide support for all stages of the disease
  • Guardant Infinity™ | Guardant Health
    Discover Guardant Infinity™, our cutting-edge platform that combines genomic, epigenomic, and RNA-based profiling to deliver multiomic insights
  • Guardant Health Reports Third Quarter 2025 Financial Results and . . .
    Revenue growth of 39% broadly driven by strong performance across Oncology, Screening, and Biopharma Data Raises 2025 revenue guidance to $965 to $970 million, representing year-over-year growth of 31% Guardant Health, Inc (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter ended September 30, 2025 Third Quarter 2025 Financial Highlights For





中文字典-英文字典  2005-2009